Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
San Jorge Children's Hospital
mi
from
San Juan,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Karmanos Cancer Insitute
mi
from
Detroit, MI
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Boston, MA
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
Status: Enrolling, Phase III
Updated: 12/31/1969
Incyte Investigative Site
mi
from
Wilmington, DE
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Spruce Biosciences Clinical Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
Spruce Biosciences Clinical Site
mi
from
Orange, CA
Click here to add this to my saved trials
Relapsed and/or Refractory Multiple Myeloma Clinical Trial
An Efficacy Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Louisiana Hematology Oncology Clinic
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of AZD5991 in Relapsed or Refractory Haematologic Malignancies.
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Hemophilia A, Congenital Clinical Trial
Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
Status: Enrolling, Phase
Updated: 12/31/1969
Hemophilia Center of Western New York
mi
from
Buffalo, NY
Click here to add this to my saved trials
Hemophilia A, Congenital Clinical Trial
Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
Status: Enrolling, Phase
Updated: 12/31/1969
Henry Ford Hospital Adult Hemophilia and Thrombosis Treatment Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Anemia, Hemolytic, Autoimmune Clinical Trial
A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)
Status: Enrolling, Phase I
Updated: 3/13/2018
University of California San Francisco - Outpatient Hematology Clinic/Infusion Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Acute Myeloid Leukaemia Clinical Trial
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Patients.
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Polycythemia Vera Clinical Trial
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Kansas Cancer Center; Westwood Cancer Center/BMT Output Clinic
mi
from
Kansas City, KS
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Study of AMG 673 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Smoldering Multiple Myeloma Clinical Trial
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Hospital Aleman ( Site 0401)
mi
from
Buenos Aires,
Click here to add this to my saved trials
Smoldering Multiple Myeloma Clinical Trial
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
VA Southern Nevada Healthcare
mi
from
North Las Vegas, NV
Click here to add this to my saved trials
Hemophilia B Clinical Trial
Long-term Safety and Efficacy Study of SPK-9001 in Individuals With Hemophilia B
Status: Enrolling, Phase II
Updated: 12/31/1969
UC Davis Health
mi
from
Sacramento, CA
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Hollywood, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of GBR 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Glenmark Investigational Site 2
mi
from
Little Rock, AR
Click here to add this to my saved trials
Relapsed/Refractory Multiple Myeloma Clinical Trial
A Phase 1 Study of AMG 701 in Subjects With Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Relapsed/Refractory Multiple Myeloma Clinical Trial
A Phase 1 Study of AMG 701 in Subjects With Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Relapsed/Refractory Multiple Myeloma Clinical Trial
A Phase 1 Study of AMG 701 in Subjects With Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma (MM) Previously Receiving a Bortezomib-based Induction Regimen (US MM-6)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Regional Cancer Care Associates LLC
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma (MM) Previously Receiving a Bortezomib-based Induction Regimen (US MM-6)
Status: Enrolling, Phase IV
Updated: 12/31/1969
US Oncology Research
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma (MM) Previously Receiving a Bortezomib-based Induction Regimen (US MM-6)
Status: Enrolling, Phase IV
Updated: 12/31/1969
Texas Oncology Presbyterian Cancer Center Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma (MM) Previously Receiving a Bortezomib-based Induction Regimen (US MM-6)
Status: Enrolling, Phase IV
Updated: 12/31/1969
CARTI Cancer Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Dose-Ranging Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 in Subjects With Severe Hemophilia A
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Emory University, Dept. of Hematology
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hematologic Malignancies Clinical Trial
GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Colorado - Aurora Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
VCRC Tissue Repository
Status: Enrolling, Phase
Updated: 12/31/1969
St. Joseph's Healthcare
mi
from
Hamilton,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of CLR 131 in Relapsed or Refractory Select B-Cell Malignancies (CLOVER-1)
Status: Enrolling, Phase II
Updated: 12/31/1969
Cellectar Biosciences site
mi
from
Rochester, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of CLR 131 in Relapsed or Refractory Select B-Cell Malignancies (CLOVER-1)
Status: Enrolling, Phase II
Updated: 12/31/1969
Cellectar Biosciences site
mi
from
Warrenville, IL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Commonwealth Hematology
mi
from
Danville, KY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
Status: Enrolling, Phase III
Updated: 12/31/1969
Prairie Lakes Healthcare
mi
from
Watertown, SD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Dose-Escalation Study of BFCR4350A in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic Hospital - Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Hematological Malignancies Clinical Trial
Dose Escalation Study of JNJ-64007957, a Humanized BCMA CD3 DuoBody® Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai Program for the Protection of Human Subjects
mi
from
New York, NY
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Mayfield Heights, OH
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
Status: Enrolling, Phase III
Updated: 12/31/1969
US08
mi
from
Charleston, SC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
Status: Enrolling, Phase III
Updated: 12/31/1969
US04
mi
from
East Setauket, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
Status: Enrolling, Phase III
Updated: 12/31/1969
US01
mi
from
Fresno, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
Status: Enrolling, Phase III
Updated: 12/31/1969
US17
mi
from
Tucson, AZ
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase I
Updated: 12/31/1969
Site CA00010
mi
from
Toronto,
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ohio State University, The
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber Cancer Institute /ID# 163440
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Seattle Children's Hospital /ID# 163459
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers (Aurora) - USOR
mi
from
Aurora, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Florida Cancer Specialists South
mi
from
Bonita Springs, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology (Medical City) - USOR
mi
from
Dallas, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers (Littleton) - USOR
mi
from
Littleton, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Cancer Centers (Longmont) - USOR
mi
from
Longmont, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Tennessee Oncolgy - Baptist
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Tennessee Oncology - Skyline
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology (E Common) - USOR
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology - San Antonio Medical Center - USOR
mi
from
San Antonio, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Florida Cancer Specialists South
mi
from
Venice, FL
Click here to add this to my saved trials
Myelofibrosis Clinical Trial
A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple M
Status: Enrolling, Phase II
Updated: 12/31/1969
Levine Cancer Institute - Main
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
UNC Hemophilia and Thrombosis Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Los Angeles Orthopedic Hospital, Orthopedic Hemophilia Treatment Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California San Diego, Hematology and Oncology, Hemophilia &Thrombosis Treatment Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Beta-Thalassemia Clinical Trial
A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Marseille,
Click here to add this to my saved trials
Beta-Thalassemia Clinical Trial
A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials
Chronic Phase Chronic Myeloid Leukemia Clinical Trial
Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States
Status: Enrolling, Phase
Updated: 12/31/1969
Healthcare Research Network
mi
from
Tinley Park, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Health Dallas University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Benign Prostatic Hyperplasia Clinical Trial
Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)
Status: Enrolling, Phase II
Updated: 4/23/2018
Bayview Research Group, LLC - Valley Village
mi
from
Valley Village, CA
Click here to add this to my saved trials
Beta-Thalassemia Clinical Trial
A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Adult Patients With Transfusion-Dependent Beta Thalassemia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Camperdown,
Click here to add this to my saved trials
Beta-Thalassemia Clinical Trial
A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Adult Patients With Transfusion-Dependent Beta Thalassemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Beta-Thalassemia Clinical Trial
A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Adult Patients With Transfusion-Dependent Beta Thalassemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Solid Organ Transplant Subjects With EBV+ PTLD After Failure of Rituximab or Rituximab and Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Texas MD Anderson Cancer Center (Adults and Pediatrics)
mi
from
Houston, TX
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Solid Organ Transplant Subjects With EBV+ PTLD After Failure of Rituximab or Rituximab and Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Loyola University Medical Center (Adults and Pediatrics)
mi
from
Maywood, IL
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Solid Organ Transplant Subjects With EBV+ PTLD After Failure of Rituximab or Rituximab and Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Yale University (Adults and Pediatrics)
mi
from
New Haven, CT
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Solid Organ Transplant Subjects With EBV+ PTLD After Failure of Rituximab or Rituximab and Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center (Adults and Pediatrics)
mi
from
New York, NY
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Solid Organ Transplant Subjects With EBV+ PTLD After Failure of Rituximab or Rituximab and Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Children's Hospital of Philadelphia (Pediatrics only)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV-Associated Lymphoid Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Georgia Cancer Center at Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Atypical Hemolytic Uremic Syndrome (aHUS) Clinical Trial
Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Hollywood, FL
Click here to add this to my saved trials
Atypical Hemolytic Uremic Syndrome (aHUS) Clinical Trial
Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Akron, OH
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Akron, OH
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Emory University School of Medicine; Department of Human Genetics
mi
from
Atlanta, GA
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center - Human Genetics Dept.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder Clinical Trial
Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With EBV+ PTLD After Failure of Rituximab
Status: Enrolling, Phase III
Updated: 12/31/1969
Montefiore Medical Center (Pediatrics only)
mi
from
Bronx, NY
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg
Status: Enrolling, Phase III
Updated: 12/31/1969
UF Shands Cancer Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg
Status: Enrolling, Phase III
Updated: 12/31/1969
UC Davis Hemophilia Treatment Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia
Status: Enrolling
Updated: 12/31/1969
John Hopkins University School of Medicine/Johns Hopkins Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622
Status: Enrolling, Phase III
Updated: 12/31/1969
GSK Investigational Site
mi
from
Bruxelles,
Click here to add this to my saved trials
Hematology, Orthopedics / Podiatry Clinical Trial
Ultrasonography in Hemophilic Joint Disease and Serum Markers
Status: Enrolling, Phase
Updated: 4/4/2018
Feinstein Institute of Medical Research Northwell Health
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome
Status: Enrolling, Phase I
Updated: 12/31/1969
The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
Status: Enrolling, Phase II
Updated: 12/31/1969
Montefiore Medical Center Division of Hematology, Department of Oncology
mi
from
Bronx, NY
Click here to add this to my saved trials